Position in NAUT
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$254,417
-$273,464 QoQ
Shares Held
136,052
0.0% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#29
of 93 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crewe Advisors LLC holds $953,982 across 16 Biotechnology names. NAUT ranks #2 (26.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
563 | $279,658 | |
| 2 | NAUT |
Nautilus Biotechnology, Inc.
This page
|
136,052 | $254,417 | |
| 3 | DFTX |
Definium Therapeutics, Inc.
|
1,999 | $94,032 | |
| 4 | BNTX |
BioNTech SE
|
809 | $75,277 | |
| 5 | MRNA |
Moderna, Inc.
|
728 | $50,981 | |
| 6 | MNKD |
Mannkind Corp
|
8,074 | $34,395 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
94 | $29,712 | |
| 8 | ATAI |
AtaiBeckley Inc.
|
5,540 | $29,195 |
All Filings in NAUT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,417 | 136,052 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $527,881 | 136,052 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $265,301 | 136,052 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $114,963 | 136,052 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||